Index RUT
P/E -
EPS (ttm) -0.37
Insider Own 3.81%
Shs Outstand 102.82M
Perf Week -5.25%
Market Cap 780.36M
Forward P/E 6.50
EPS next Y 1.17
Insider Trans -0.48%
Shs Float 99.02M
Perf Month -14.25%
Income 18.18M
PEG -
EPS next Q 0.25
Inst Own 97.26%
Short Float 15.84%
Perf Quarter -31.83%
Sales 716.29M
P/S 1.09
EPS this Y 3.73%
Inst Trans -3.95%
Short Ratio 5.54
Perf Half Y -14.25%
Book/sh 9.19
P/B 0.83
EPS next Y 2.20%
ROA 0.87%
Short Interest 15.68M
Perf Year -52.30%
Cash/sh 3.21
P/C 2.36
EPS next 5Y 20.00%
ROE 1.76%
52W Range 7.32 - 18.77
Perf YTD -33.27%
Dividend Est. -
P/FCF 4.78
EPS past 5Y -20.81%
ROI 1.51%
52W High -59.62%
Beta 1.26
Dividend TTM -
Quick Ratio 0.80
Sales past 5Y 24.38%
Gross Margin 73.80%
52W Low 3.55%
ATR (14) 0.32
Dividend Ex-Date -
Current Ratio 0.80
EPS Y/Y TTM -92.59%
Oper. Margin -1.84%
RSI (14) 35.57
Volatility 4.20% 3.82%
Employees 1979
Debt/Eq 0.65
Sales Y/Y TTM -6.60%
Profit Margin 2.54%
Recom 3.40
Target Price 9.53
Option/Short Yes / Yes
LT Debt/Eq 0.28
EPS Q/Q -903.42%
Payout 0.00%
Rel Volume 0.92
Prev Close 7.37
Sales Surprise 1.10%
EPS Surprise -1.07%
Sales Q/Q -8.39%
Earnings Feb 05 AMC
Avg Volume 2.83M
Price 7.58
SMA20 -6.67%
SMA50 -14.88%
SMA200 -20.18%
Trades
Volume 2,580,980
Change 2.85%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-11-24 Resumed
JP Morgan
Neutral
$9
Feb-06-24 Downgrade
Piper Sandler
Neutral → Underweight
$9 → $8.50
Jan-19-24 Downgrade
Goldman
Neutral → Sell
$10 → $8
Nov-20-23 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$10 → $9
May-02-23 Downgrade
Jefferies
Buy → Hold
$25 → $11
May-02-23 Downgrade
Barrington Research
Outperform → Mkt Perform
Apr-20-23 Upgrade
Craig Hallum
Hold → Buy
$20 → $25
Feb-07-23 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Jan-19-23 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$29
Jan-18-23 Downgrade
Needham
Buy → Hold
Sep-26-22 Upgrade
Needham
Hold → Buy
$28
Sep-08-22 Upgrade
Northland Capital
Market Perform → Outperform
$30
Jul-15-22 Initiated
Goldman
Neutral
$20
May-03-22 Downgrade
William Blair
Outperform → Mkt Perform
May-03-22 Downgrade
Piper Sandler
Overweight → Neutral
$44 → $21
Apr-12-22 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Jan-13-22 Upgrade
Piper Sandler
Neutral → Overweight
$54 → $43
Nov-03-21 Downgrade
Northland Capital
Outperform → Market Perform
$54
Nov-02-21 Downgrade
Raymond James
Outperform → Mkt Perform
Nov-02-21 Downgrade
Piper Sandler
Overweight → Neutral
$107 → $54
Show Previous Ratings
Mar-27-24 09:00AM
Mar-26-24 07:48AM
07:09AM
Mar-24-24 06:19PM
03:47PM
03:42PM
Loading…
03:42PM
Mar-21-24 11:01PM
Mar-20-24 09:01PM
08:29PM
Mar-15-24 11:43AM
Mar-14-24 04:05PM
Mar-06-24 03:17PM
Mar-04-24 07:25PM
Feb-28-24 10:21AM
Feb-22-24 03:32PM
07:42AM
Loading…
Feb-19-24 07:42AM
Feb-15-24 11:52AM
Feb-13-24 10:00AM
Feb-12-24 05:29PM
Feb-06-24 06:49PM
04:38PM
01:29PM
11:37AM
08:41AM
08:11AM
07:23AM
(Thomson Reuters StreetEvents)
05:58AM
Feb-05-24 06:00PM
04:42PM
04:24PM
(Associated Press Finance)
04:18PM
Loading…
04:18PM
04:14PM
04:07PM
04:05PM
Feb-04-24 04:28PM
02:01AM
Feb-03-24 11:45AM
Jan-26-24 08:57PM
Jan-22-24 03:35AM
Jan-19-24 04:45PM
04:37PM
03:10PM
12:47PM
Jan-12-24 07:30AM
Jan-11-24 04:30PM
08:57AM
Jan-08-24 05:04PM
10:15AM
Jan-02-24 09:30AM
Dec-27-23 05:50AM
Dec-20-23 06:06PM
Dec-06-23 09:10AM
Dec-03-23 07:03AM
Nov-29-23 10:45AM
Nov-28-23 01:09PM
Nov-21-23 12:32PM
Nov-20-23 04:11PM
(Yahoo Finance Video) -6.21%
12:44PM
12:17PM
(Investor's Business Daily)
11:03AM
(Investor's Business Daily)
07:00AM
Nov-19-23 09:00AM
Nov-18-23 08:14AM
Nov-15-23 06:02PM
02:42PM
06:45AM
Nov-08-23 04:05PM
Nov-06-23 01:19PM
Oct-31-23 12:52PM
11:42AM
08:55AM
05:04AM
01:07AM
Oct-30-23 07:00PM
05:58PM
05:50PM
05:44PM
04:41PM
(Associated Press Finance)
04:32PM
04:26PM
Oct-25-23 10:02AM
Oct-17-23 05:20PM
Oct-16-23 04:44PM
Oct-11-23 11:15AM
Oct-09-23 11:40AM
09:40AM
Oct-04-23 04:45PM
Oct-03-23 08:00AM
Sep-29-23 02:19PM
08:32AM
Sep-28-23 05:00PM
Sep-25-23 11:22AM
Sep-15-23 11:02AM
Sep-08-23 10:32AM
Sep-04-23 04:41PM
Sep-03-23 09:13AM
Aug-30-23 08:03AM
Aug-24-23 03:32PM
Aug-23-23 04:33PM
09:58AM
Chegg, Inc. engages in providing support and a learning platform for students. Its services include Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, Busuu offerings, Chegg Skills, advertising services, print textbooks, and eTextbooks offerings. The company was founded by Osman Rashid and Aayush Phumbhra on July 29, 2005 and is headquartered in Santa Clara, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Schultz Nathan J. CHIEF OPERATING OFFICER Dec 13 '23 Sale 10.41 1,350 14,054 421,025 Dec 14 05:11 PM Schultz Nathan J. CHIEF OPERATING OFFICER Dec 04 '23 Sale 10.13 630 6,382 426,802 Dec 05 01:35 PM BROWN ANDREW J CHIEF FINANCIAL OFFICER Nov 27 '23 Sale 10.02 16,921 169,548 91,922 Nov 29 07:52 PM Schultz Nathan J. CHIEF OPERATING OFFICER Sep 13 '23 Sale 10.06 1,547 15,563 429,501 Sep 14 07:27 PM Schultz Nathan J. CHIEF OPERATING OFFICER Sep 05 '23 Sale 10.60 818 8,672 434,816 Sep 06 04:38 PM Schultz Nathan J. CHIEF OPERATING OFFICER Jun 14 '23 Sale 10.75 1,751 18,823 437,078 Jun 14 07:33 PM Schultz Nathan J. CHIEF OPERATING OFFICER Jun 05 '23 Sale 9.56 818 7,816 441,917 Jun 05 06:17 PM Levine Marne L. Director May 12 '23 Option Exercise 8.41 36,041 303,285 57,910 May 16 09:21 PM
Index S&P 500
P/E 27.50
EPS (ttm) 10.03
Insider Own 0.39%
Shs Outstand 102.54M
Perf Week 0.44%
Market Cap 28.28B
Forward P/E 14.90
EPS next Y 18.51
Insider Trans -2.87%
Shs Float 102.08M
Perf Month 0.31%
Income 1.05B
PEG 2.55
EPS next Q 3.28
Inst Own 95.45%
Short Float 0.71%
Perf Quarter 15.40%
Sales 9.48B
P/S 2.98
EPS this Y 12.96%
Inst Trans -0.49%
Short Ratio 1.59
Perf Half Y 29.39%
Book/sh 92.84
P/B 2.97
EPS next Y 13.10%
ROA 3.47%
Short Interest 0.73M
Perf Year 21.31%
Cash/sh 13.93
P/C 19.80
EPS next 5Y 10.80%
ROE 10.80%
52W Range 195.29 - 278.86
Perf YTD 14.39%
Dividend Est. 3.46 (1.26%)
P/FCF 23.72
EPS past 5Y 13.58%
ROI 7.18%
52W High -1.05%
Beta 0.74
Dividend TTM 3.40 (1.23%)
Quick Ratio -
Sales past 5Y 2.35%
Gross Margin 75.53%
52W Low 41.29%
ATR (14) 3.34
Dividend Ex-Date Mar 27, 2024
Current Ratio -
EPS Y/Y TTM 4.09%
Oper. Margin 19.31%
RSI (14) 60.92
Volatility 1.04% 1.20%
Employees 48000
Debt/Eq 0.62
Sales Y/Y TTM -18.15%
Profit Margin 11.13%
Recom 2.09
Target Price 294.83
Option/Short Yes / Yes
LT Debt/Eq 0.54
EPS Q/Q 11.82%
Payout 33.76%
Rel Volume 0.92
Prev Close 274.14
Sales Surprise 0.37%
EPS Surprise 5.50%
Sales Q/Q -46.44%
Earnings Feb 06 BMO
Avg Volume 457.99K
Price 275.92
SMA20 0.87%
SMA50 3.63%
SMA200 17.47%
Trades
Volume 420,782
Change 0.65%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-12-24 Upgrade
Citigroup
Neutral → Buy
$236 → $315
Feb-12-24 Upgrade
BMO Capital Markets
Underperform → Market Perform
$236 → $298
Jan-11-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$248 → $288
Jan-10-24 Initiated
TD Cowen
Outperform
$316
Aug-08-23 Downgrade
BMO Capital Markets
Market Perform → Underperform
$230 → $205
Jul-27-23 Downgrade
Raymond James
Strong Buy → Outperform
$260
Jun-20-23 Initiated
Morgan Stanley
Equal-Weight
$251
Feb-27-23 Upgrade
Goldman
Neutral → Buy
$290
Jan-20-23 Initiated
BMO Capital Markets
Market Perform
$260
Jan-18-23 Upgrade
Keefe Bruyette
Mkt Perform → Outperform
$303
Dec-15-22 Initiated
Citigroup
Neutral
$247
Oct-13-22 Upgrade
Piper Sandler
Neutral → Overweight
$250
Sep-26-22 Initiated
Credit Suisse
Outperform
$288
Jul-12-22 Initiated
Goldman
Neutral
$227
Apr-11-22 Resumed
BofA Securities
Underperform
$245
Feb-09-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$284 → $240
Dec-16-21 Initiated
Evercore ISI
In-line
$240
Nov-19-21 Initiated
Jefferies
Hold
$258
Oct-20-21 Downgrade
Wolfe Research
Outperform → Peer Perform
$283 → $244
Sep-10-21 Reiterated
MKM Partners
Buy
$250 → $285
Show Previous Ratings
Mar-26-24 07:05AM
Mar-20-24 07:18AM
Mar-18-24 04:30AM
Mar-14-24 05:30AM
Mar-07-24 11:31AM
05:15AM
Loading…
05:15AM
Mar-04-24 11:00AM
Feb-29-24 04:00PM
Feb-28-24 09:22AM
Feb-27-24 10:59AM
Feb-26-24 10:17AM
Feb-23-24 12:09AM
Feb-21-24 12:00PM
08:44AM
Feb-14-24 08:21PM
08:49AM
Loading…
Feb-12-24 08:49AM
Feb-10-24 03:00AM
Feb-07-24 09:00PM
02:22PM
(Investor's Business Daily)
10:38AM
Feb-06-24 12:30PM
(Morningstar Research) +7.18%
09:30AM
09:25AM
07:13AM
07:10AM
06:32AM
06:00AM
Feb-01-24 09:22AM
09:15AM
Jan-30-24 10:00AM
08:32AM
Loading…
Jan-29-24 08:32AM
Jan-25-24 08:18AM
Jan-24-24 09:05AM
Jan-22-24 09:05AM
08:00AM
Jan-17-24 08:00AM
Jan-10-24 09:00AM
Jan-09-24 04:05PM
Jan-04-24 07:47AM
07:07AM
Jan-03-24 08:23AM
06:42AM
Jan-02-24 10:23AM
Dec-27-23 05:10AM
Dec-14-23 03:30AM
Dec-12-23 09:29AM
Dec-11-23 08:00AM
Dec-07-23 05:21PM
10:21AM
Dec-06-23 07:57AM
Dec-05-23 04:05PM
Dec-04-23 08:00AM
Nov-30-23 07:44AM
Nov-29-23 09:06AM
06:00AM
Nov-27-23 12:46PM
Nov-14-23 12:50PM
Nov-13-23 04:03PM
04:03PM
Nov-08-23 05:41AM
Nov-02-23 11:34AM
(Investor's Business Daily)
Nov-01-23 07:00AM
Oct-28-23 02:32PM
Oct-27-23 12:14PM
Oct-26-23 08:24PM
(Morningstar Research) +10.27%
10:52AM
09:30AM
07:50AM
07:42AM
07:15AM
06:00AM
Oct-23-23 12:00PM
07:56AM
Oct-20-23 09:45AM
Oct-19-23 10:01AM
Oct-17-23 10:04AM
Oct-16-23 04:57AM
Oct-12-23 09:56AM
08:04AM
Oct-11-23 02:59AM
Oct-10-23 04:12PM
Oct-06-23 05:04AM
Oct-04-23 02:58PM
Sep-29-23 07:06AM
Sep-28-23 07:09AM
Sep-26-23 10:53AM
Sep-21-23 09:04AM
Sep-19-23 07:32PM
Sep-11-23 11:01AM
Aug-31-23 05:00PM
Aug-27-23 09:31AM
Aug-23-23 07:15AM
Aug-16-23 11:22AM
Aug-15-23 09:30AM
Aug-10-23 07:06AM
Aug-09-23 09:00AM
Aug-08-23 08:18PM
07:32PM
02:19AM
Aug-01-23 03:35PM
Willis Towers Watson Plc engages in the provision of advisory, broking, and solutions services. It operates through the following segments: Health, Wealth, and Career (HCW), Risk and Broking (R&B), and Corporate and Other. The HCW segment provides an array of advice, broking, solutions, and technology for employee benefit plans, institutional investors, compensation and career programs, and the employee experience overall. The R&B segment focuses on a broad range of risk advice, insurance brokerage, and consulting services to clients globally, ranging from small businesses to multinational corporations. The company was founded in 1828 and is headquartered in London, the United Kingdom.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Krasner Andrew Jay Chief Financial Officer Mar 01 '24 Sale 272.13 1,100 299,346 4,170 Mar 05 04:01 PM Gebauer Julie Jarecke Head of Health, Wealth &Career Feb 20 '24 Sale 276.03 5,000 1,380,144 68,574 Feb 22 04:00 PM Garrard Adam Head of Risk & Broking Feb 08 '24 Sale 270.41 5,400 1,460,214 11,259 Feb 12 04:00 PM Thomson-Hall Pamela Head of International Nov 09 '23 Sale 238.87 330 78,827 3,324 Nov 13 04:02 PM Gebauer Julie Jarecke Head of Health, Wealth &Career Jul 03 '23 Sale 231.69 2,000 463,384 75,240 Jul 05 04:01 PM Pullum Anne Head of Europe Jun 07 '23 Sale 224.45 5,000 1,122,230 12,791 Jun 09 04:00 PM Gebauer Julie Jarecke Head of Health, Wealth &Career Jun 01 '23 Sale 218.35 2,500 545,868 77,240 Jun 01 04:01 PM Gebauer Julie Jarecke Head of Health, Wealth &Career May 01 '23 Sale 231.44 2,500 578,590 79,740 May 02 04:01 PM Krasner Andrew Jay Chief Financial Officer Apr 17 '23 Option Exercise 0.00 2 0 11,647 Apr 19 09:10 PM Bodnar Anne Donovan Chief Administrative Officer Apr 17 '23 Option Exercise 0.00 1 0 9,105 Apr 19 09:09 PM Garrard Adam Head of Risk & Broking Apr 17 '23 Option Exercise 0.00 1 0 18,384 Apr 19 09:08 PM Qureshi Imran Ahmed Head of North America Apr 17 '23 Option Exercise 0.00 1 0 3,535 Apr 19 09:03 PM Furman Matthew General Counsel Apr 17 '23 Option Exercise 0.00 1 0 31,834 Apr 19 09:04 PM Hess Carl Aaron Chief Executive Officer Apr 17 '23 Option Exercise 0.00 9 0 73,376 Apr 19 09:03 PM Gebauer Julie Jarecke Head of Health, Wealth &Career Apr 17 '23 Option Exercise 0.00 1 0 82,241 Apr 19 09:02 PM Pullum Anne Head of Europe Apr 17 '23 Option Exercise 0.00 1 0 17,792 Apr 19 09:01 PM Gebauer Julie Jarecke Head of Health, Wealth &Career Apr 03 '23 Sale 232.38 2,500 580,941 82,312 Apr 04 05:08 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite